Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models

MLA

Spangler, Dennis L., et al. “Randomized, Double-Masked Comparison of Olopatadine Ophthalmic Solution, Mometasone Furoate Monohydrate Nasal Spray, and Fexofenadine Hydrochloride Tablets Using the Conjunctival and Nasal Allergen Challenge Models.” Clinical Therapeutics, vol. 25, no. 8, Aug. 2003, p. 2245. EBSCOhost, https://doi.org/10.1016/S0149-2918(03)80217-5.

APA

Spangler, D. L., Abelson, M. B., Ober, A., & Gotnes, P. J. (2003). Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clinical Therapeutics, 25(8), 2245. https://doi.org/10.1016/S0149-2918(03)80217-5

Chicago

Spangler, Dennis L., Mark B. Abelson, Andrew Ober, and Paulo J. Gotnes. 2003. “Randomized, Double-Masked Comparison of Olopatadine Ophthalmic Solution, Mometasone Furoate Monohydrate Nasal Spray, and Fexofenadine Hydrochloride Tablets Using the Conjunctival and Nasal Allergen Challenge Models.” Clinical Therapeutics 25 (8): 2245. doi:10.1016/S0149-2918(03)80217-5.